Latest Financials News

360 Capital Group (ASX, TGP) has received an unconditional on-market takeover bid from TT Investments at $0.31 per stapled security. The Independent Board Committee unanimously recommends acceptance, supported by an Independent Expert's fair and reasonable opinion.

European Metals Holdings has released a Definitive Feasibility Study confirming the Cinovec Lithium Project as a long-life, battery-grade lithium carbonate producer strategically positioned to supply Europe's electric vehicle and energy storage sectors.

Aguia Resources has implemented strategic operational changes at its Santa Barbara Gold Project in Colombia, achieving a 70% gold recovery rate in December and targeting over 80% in early 2026.

Zoono Group Limited has responded to ASX queries confirming ongoing collaboration with OSY Group Limited, acknowledging delays in meeting sales targets but highlighting steady contract progress and future order potential.

Globe Metals & Mining has issued over 56 million shares to Director Bo Tan, settling nearly all of an outstanding loan and achieving a fully debt-free status. This financial milestone positions the company strongly for advancing its Kanyika Niobium Project.

Renascor Resources has completed major equipment installation and begun commissioning at its Australian Government co-funded Purified Spherical Graphite demonstration facility, marking a pivotal step in its sustainable battery anode materials strategy.

Janus Henderson Investors has announced the distribution timetable for its Global Sustainable Equity Active ETF for the period ending December 2025, outlining key dates and reinvestment options for investors.

Latrobe Magnesium Limited has received a $6.29 million R&D tax rebate from the ATO, using the funds to reduce debt and progress its magnesium production plants in Australia and Malaysia.

Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.

Carnegie Clean Energy’s Spanish subsidiary has sold its 2025 Basque R&D tax deductions for €773,163, securing immediate funding to advance its ocean wave energy technology under the ACHIEVE Programme.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.

OZZ Resources has entered a binding option agreement with Scorpion Minerals, offering an exclusive chance to acquire its key tenements for $2.6 million plus a gold production royalty. The deal awaits shareholder approval and hinges on several regulatory and operational conditions.